This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bandyopadhyay, S. Articles by Watabe, K. Search for Related Content PubMed PubMed Citation Articles by Bandyopadhyay, S. Articles by Watabe, K.

The Tumor Metastasis Suppressor Gene Drg-1 Down-regulates the Expression of Activating Transcription Factor 3 in Prostate Cancer

¹ Department of Medical Microbiology and Immunology, Southern Illinois University School of Medicine, Springfield, Illinois; ² Akita Red Cross Hospital, Akita City, Japan; ³ Université Montpellier II, Montpellier, France; and ⁴ Ohio State University, Columbus, Ohio

Requests for reprints: Kounosuke Watabe, Department of Medical Microbiology and Immunology, Southern Illinois University School of Medicine, 801 North Rutledge Street, P.O. Box 19626, Springfield, IL 62794-9626. Phone: 217-545-3969; Fax: 217-545-3227; E-mail: kwatabe{at}siumed.edu.

The tumor metastasis suppressor gene Drg-1 has been shown to suppress metastasis without affecting tumorigenicity in immunodeficient mouse models of prostate and colon cancer. Expression of Drg-1 has also been found to have a significant inverse correlation with metastasis or invasiveness in various types of human cancer. However, how Drg-1 exerts its metastasis suppressor function remains unknown. In the present study, to elucidate the mechanism of action of the Drg-1 gene, we did a microarray analysis and found that induction of Drg-1 significantly inhibited the expression of activating transcription factor (ATF) 3, a member of the ATF/cyclic AMP–responsive element binding protein family of transcription factors. We also showed that Drg-1 attenuated the endogenous level of ATF3 mRNA and protein in prostate cancer cells, whereas Drg-1 small interfering RNA up-regulated the ATF3 expression. Furthermore, Drg-1 suppressed the promoter activity of the ATF3 gene, indicating that Drg-1 regulates ATF3 expression at the transcriptional level. Our immunohistochemical analysis on prostate cancer specimens revealed that nuclear expression of ATF3 was inversely correlated to Drg-1 expression and positively correlated to metastases. Consistently, we have found that ATF3 overexpression promoted invasiveness of prostate tumor cells in vitro, whereas Drg-1 suppressed the invasive ability of these cells. More importantly, overexpression of ATF3 in prostate cancer cells significantly enhanced spontaneous lung metastasis of these cells without affecting primary tumorigenicity in a severe combined immunodeficient mouse model. Taken together, our results strongly suggest that Drg-1 suppresses metastasis of prostate tumor cells, at least in part, by inhibiting the invasive ability of the cells via down-regulation of the expression of the ATF3 gene. (Cancer Res 2006; 66(24): 11983-90)

This article has been cited by other articles:

				K. Miyazaki, S. Inoue, K. Yamada, M. Watanabe, Q. Liu, T. Watanabe, M. T. Adachi, Y. Tanaka, and S. Kitajima Differential usage of alternate promoters of the human stress response gene ATF3 in stress response and cancer cells Nucleic Acids Res., April 1, 2009; 37(5): 1438 - 1451. [Abstract] [Full Text] [PDF]

				X. Huang, X. Li, and B. Guo KLF6 Induces Apoptosis in Prostate Cancer Cells through Up-regulation of ATF3 J. Biol. Chem., October 31, 2008; 283(44): 29795 - 29801. [Abstract] [Full Text] [PDF]

				X. Ouyang, W. J. Jessen, H. Al-Ahmadie, A. M. Serio, Y. Lin, W.-J. Shih, V. E. Reuter, P. T. Scardino, M. M. Shen, B. J. Aronow, et al. Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer Cancer Res., April 1, 2008; 68(7): 2132 - 2144. [Abstract] [Full Text] [PDF]

				M. Milstein, C. K. Mooser, H. Hu, M. Fejzo, D. Slamon, L. Goodglick, S. Dry, and J. Colicelli RIN1 Is a Breast Tumor Suppressor Gene Cancer Res., December 15, 2007; 67(24): 11510 - 11516. [Abstract] [Full Text] [PDF]